Literature DB >> 8202105

Cancer therapy meets p53.

K W Kinzler1, B Vogelstein.   

Abstract

Entities:  

Mesh:

Year:  1994        PMID: 8202105     DOI: 10.1056/NEJM199407073310113

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  16 in total

1.  Inhibition of cyclin-dependent kinase activity and induction of apoptosis by preussin in human tumor cells.

Authors:  T V Achenbach; E P Slater; H Brummerhop; T Bach; R Müller
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

2.  Evaluation of noncytotoxic DNMT1-depleting therapy in patients with myelodysplastic syndromes.

Authors:  Yogen Saunthararajah; Mikkael Sekeres; Anjali Advani; Reda Mahfouz; Lisa Durkin; Tomas Radivoyevitch; Ricki Englehaupt; Joy Juersivich; Kathleen Cooper; Holleh Husseinzadeh; Bartlomiej Przychodzen; Matthew Rump; Sean Hobson; Marc Earl; Ronald Sobecks; Robert Dean; Frederic Reu; Ramon Tiu; Betty Hamilton; Edward Copelan; Alan Lichtin; Eric Hsi; Matt Kalaycio; Jaroslaw Maciejewski
Journal:  J Clin Invest       Date:  2015-01-26       Impact factor: 14.808

3.  Molecular pathology and cancer genetic screening.

Authors:  J P Gregg; W W Grody
Journal:  West J Med       Date:  1995-05

4.  Expression of p53 and bcl-2 and response to preoperative chemotherapy and radiotherapy for locally advanced squamous cell carcinoma of the oesophagus.

Authors:  F Puglisi; C Di Loreto; R Panizzo; C Avellini; S Fongione; V Cacitti; C A Beltrami
Journal:  J Clin Pathol       Date:  1996-06       Impact factor: 3.411

5.  Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis.

Authors:  L W Elmore; A R Hancock; S F Chang; X W Wang; S Chang; C P Callahan; D A Geller; H Will; C C Harris
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

Review 6.  Molecular oncology in pancreatic cancer.

Authors:  S Gansauge; F Gansauge; H G Beger
Journal:  J Mol Med (Berl)       Date:  1996-06       Impact factor: 4.599

7.  Genes mediating programmed cell death: an immunohistochemical study of bcl-2, c-myc and p53 expression in colorectal neoplasia.

Authors:  N Scott; I Martin; A S Jack; M F Dixon; P Quirke
Journal:  Clin Mol Pathol       Date:  1996-06

8.  The p53 gene is a potent determinant of chemosensitivity and radiosensitivity in gastric and colorectal cancers.

Authors:  M Hamada; T Fujiwara; A Hizuta; A Gochi; Y Naomoto; N Takakura; K Takahashi; J A Roth; N Tanaka; K Orita
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

9.  Molecular diagnosis of p53 mutations in gastric carcinoma by touch preparation.

Authors:  E Ricevuto; C Ficorella; C Fusco; K Cannita; A Tessitore; E Toniato; A Gabriele; L Frati; P Marchetti; A Gulino; S Martinotti
Journal:  Am J Pathol       Date:  1996-02       Impact factor: 4.307

10.  Mutational analysis of KRAS, BRAF, and TP53 genes of ovarian serous carcinomas in Korean women.

Authors:  Yun-Hyun Cho; Dae-Yeon Kim; Jong-Hyeok Kim; Yong-Man Kim; Kyu-Rae Kim; Joo-Hyun Nam; Young-Tak Kim
Journal:  Yonsei Med J       Date:  2009-04-30       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.